장 건강 제품 시장 예측(-2034년) : 제품 유형, 제품 형태, 원료원, 용도, 최종사용자, 유통 채널, 지역별 세계 분석

According to Stratistics MRC, the Global Gut Health Products Market is accounted for $53.1 billion in 2026 and is expected to reach $103.6 billion by 2034 growing at a CAGR of 8.7% during the forecast period. Gut health products encompass a diverse range of dietary supplements, functional foods, and beverages designed to support digestive wellness through probiotics, prebiotics, postbiotics, and digestive enzymes. These products target the maintenance of a balanced gut microbiome, which is increasingly recognized as critical for overall health including immune function, mental well-being, and metabolic regulation. The market has expanded significantly as scientific research continues to unveil the complex connections between gut health and chronic disease prevention, driving consumer interest across all demographic segments worldwide.

Market Dynamics:

Driver:

Rising prevalence of digestive disorders globally

Increasing incidence of irritable bowel syndrome, inflammatory bowel disease, acid reflux, and constipation is fueling demand for gut health solutions across all age groups. Sedentary lifestyles, processed food consumption, and rising stress levels contribute to gastrointestinal complaints that affect approximately one in five adults worldwide. Healthcare professionals increasingly recommend probiotic and prebiotic interventions as first-line approaches for managing mild to moderate digestive symptoms. This clinical endorsement, combined with growing patient awareness of non-pharmaceutical options, accelerates market growth as consumers seek natural, preventative approaches to digestive wellness rather than reactive treatments for advanced conditions.

Restraint:

Regulatory ambiguity surrounding health claims

Confusion regarding permitted health claims on gut health product packaging significantly constrains marketing capabilities and consumer trust. Regulatory bodies across different jurisdictions maintain varying standards for substantiating probiotic strain-specific benefits, creating compliance challenges for multinational brands. Manufacturers must navigate complex approval pathways while avoiding unsubstantiated therapeutic claims that could trigger regulatory penalties. This ambiguity leads to conservative marketing approaches that fail to adequately communicate product benefits, potentially confusing consumers who struggle to distinguish between scientifically validated products and those making exaggerated claims, ultimately slowing category growth across regulated markets.

Opportunity:

Personalized gut health solutions through microbiome testing

Emerging direct-to-consumer microbiome testing technologies are creating unprecedented opportunities for customized product recommendations. Companies can now analyze individual gut bacterial compositions through simple at-home test kits, generating personalized insights about specific probiotic strains and prebiotic fibers that would benefit each unique microbiome profile. This precision approach increases product efficacy compared to one-size-fits-all supplements, justifying premium pricing and building strong customer loyalty. Subscription models combining periodic testing with tailored product deliveries represent a rapidly expanding segment, as consumers increasingly expect personalized health solutions rather than generic offerings in the digestive wellness category.

Threat:

Intense competition from functional food and beverage alternatives

Traditional gut health products face significant competitive pressure as mainstream food and beverage companies incorporate digestive wellness benefits into everyday consumables. Yogurt, kombucha, fermented vegetables, and probiotic-enhanced juices are increasingly positioned as gut health solutions, offering consumers alternatives to traditional supplement formats. Major food corporations leverage established distribution networks and brand recognition to capture market share from specialized gut health brands. This convergence of categories threatens supplement-focused companies as consumers may prefer incorporating digestive wellness into regular eating patterns rather than adding separate supplement regimens, potentially commoditizing the gut health category.

Covid-19 Impact:

The COVID-19 pandemic dramatically elevated consumer awareness of immune health and its connection to gut microbiome function. Research highlighting the role of gut health in immune response severity prompted widespread interest in probiotic and prebiotic supplementation as preventative measures. Supply chain disruptions initially affected raw material availability, but demand surged as consumers prioritized wellness purchases. The shift toward e-commerce and direct-to-consumer channels accelerated permanently, with many consumers discovering gut health products online during lockdowns and maintaining these purchasing habits. This heightened awareness has proven durable, establishing an elevated baseline for market growth post-pandemic.

The Adults segment is expected to be the largest during the forecast period

The Adults segment is expected to account for the largest market share during the forecast period, driven by the highest prevalence of digestive concerns within this demographic and greater discretionary spending power. Adults experience stress-related digestive issues from demanding work schedules, consume processed foods that disrupt microbiome balance, and increasingly seek preventative health solutions as they age. This group also demonstrates the highest awareness of gut-brain axis connections and the relationship between digestive health and conditions including anxiety, depression, and skin disorders. Marketing campaigns targeting adult consumers through social media and wellness influencers effectively reach this digitally engaged demographic, maintaining the segment's dominant market position throughout the forecast timeline.

The Online Retail segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Online Retail segment is predicted to witness the highest growth rate, transforming how consumers discover and purchase gut health products. E-commerce platforms offer access to specialized probiotic strains, subscription delivery models, and customer review systems that help consumers navigate the crowded category. Direct-to-consumer brands have pioneered digital-first strategies including educational content, microbiome testing integration, and personalized recommendation algorithms that cannot be replicated in physical retail environments. The convenience of home delivery, particularly for temperature-sensitive probiotic products requiring careful handling, further accelerates online channel adoption as consumers increasingly expect seamless digital purchasing experiences across all health and wellness categories.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high consumer awareness, strong healthcare infrastructure, and early adoption of functional food trends. The region's mature dietary supplements market provides established distribution channels and consumer trust in digestive health products. Significant investment in gut microbiome research from leading academic institutions validates product benefits and drives media coverage that educates consumers. Regulatory frameworks, while stringent, provide clear pathways for product claims that build consumer confidence. The presence of numerous innovative startups alongside established supplement manufacturers creates a competitive environment that continuously introduces new formulations and delivery formats, maintaining market leadership throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by traditional dietary practices that already incorporate fermented foods and growing awareness of preventative healthcare. Countries including China, Japan, South Korea, and India have long histories of consuming fermented products like kimchi, miso, kombucha, and lassi, creating cultural receptivity to gut health messaging. Rapid urbanization and Westernization of diets are increasing digestive disorder prevalence, driving demand for targeted solutions. Rising disposable incomes enable premium product purchases, while expanding e-commerce infrastructure reaches consumers beyond major metropolitan areas. Government healthcare modernization initiatives emphasizing preventative approaches further accelerate adoption, positioning Asia Pacific as the fastest-growing regional market for gut health products.

Key players in the market

Some of the key players in Gut Health Products Market include Nestle S.A., Danone S.A., Yakult Honsha Co. Ltd., PepsiCo Inc., Kellogg Company, General Mills Inc., Procter & Gamble Company, Abbott Laboratories, Amway Corporation, Herbalife Ltd., BioGaia AB, Chr. Hansen Holding A/S, DuPont de Nemours Inc., Arla Foods amba, and Fonterra Co-operative Group Limited.

Key Developments:

In March 2026, Fonterra completed the sale of its Mainland Group to Lactalis for $3.845 billion, a strategic move to exit consumer-facing retail and pivot toward high-value B2B gut health ingredients.

In February 2026, eneral Mills debuted its 2026 product lineup, which includes an expanded range of Nature Valley protein granolas and fiber-dense cereals designed to support digestive regularity.

In January 2025, Amway launched the Nutrilite(TM) Begin 30 Holistic Wellness Program, a 30-day guided journey centered on gut health featuring the Begin Daily GI Primer and Balance within Probiotic.

Product Types Covered:

• Probiotics
• Prebiotics
• Digestive Enzymes
• Synbiotics
• Postbiotics

Product Forms Covered:

• Capsules & Tablets
• Powders
• Liquids
• Gummies & Chewables
• Functional Food Formats
• Functional Beverages

Ingredient Sources Covered:

• Plant-Based
• Animal-Based
• Microbial-Based
• Synthetic & Bioengineered

Applications Covered:

• Digestive Health
• Immunity Enhancement
• Metabolic Health
• Weight Management
• Mental Health (Gut-Brain Axis)
• Women's Health
• Pediatric Health
• Elderly Nutrition

End Users Covered:

• Adults
• Children
• Infants
• Geriatric Population

Distribution Channels Covered:

• Supermarkets & Hypermarkets
• Pharmacies & Drug Stores
• Specialty Stores
• Online Retail
• Direct-to-Consumer (DTC)

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Gut Health Products Market, By Product Type

• 5.1 Probiotics
  • 5.1.1 Lactobacillus
  • 5.1.2 Bifidobacterium
  • 5.1.3 Streptococcus
  • 5.1.4 Yeast-Based Probiotics
  • 5.1.5 Spore-Forming Probiotics
• 5.2 Prebiotics
  • 5.2.1 Inulin
  • 5.2.2 Fructooligosaccharides (FOS)
  • 5.2.3 Galactooligosaccharides (GOS)
  • 5.2.4 Resistant Starch
  • 5.2.5 Other Prebiotics
• 5.3 Digestive Enzymes
  • 5.3.1 Protease
  • 5.3.2 Amylase
  • 5.3.3 Lipase
  • 5.3.4 Lactase
  • 5.3.5 Other Digestive Enzymes
• 5.4 Synbiotics
• 5.5 Postbiotics

6 Global Gut Health Products Market, By Product Form

• 6.1 Capsules & Tablets
• 6.2 Powders
• 6.3 Liquids
• 6.4 Gummies & Chewables
• 6.5 Functional Food Formats
• 6.6 Functional Beverages

7 Global Gut Health Products Market, By Ingredient Source

• 7.1 Plant-Based
• 7.2 Animal-Based
• 7.3 Microbial-Based
• 7.4 Synthetic & Bioengineered

8 Global Gut Health Products Market, By Application

• 8.1 Digestive Health
• 8.2 Immunity Enhancement
• 8.3 Metabolic Health
• 8.4 Weight Management
• 8.5 Mental Health (Gut-Brain Axis)
• 8.6 Women's Health
• 8.7 Pediatric Health
• 8.8 Elderly Nutrition

9 Global Gut Health Products Market, By End User

• 9.1 Adults
• 9.2 Children
• 9.3 Infants
• 9.4 Geriatric Population

10 Global Gut Health Products Market, By Distribution Channel

• 10.1 Supermarkets & Hypermarkets
• 10.2 Pharmacies & Drug Stores
• 10.3 Specialty Stores
• 10.4 Online Retail
• 10.5 Direct-to-Consumer (DTC)

11 Global Gut Health Products Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Nestle S.A.
• 14.2 Danone S.A.
• 14.3 Yakult Honsha Co. Ltd.
• 14.4 PepsiCo Inc.
• 14.5 Kellogg Company
• 14.6 General Mills Inc.
• 14.7 Procter & Gamble Company
• 14.8 Abbott Laboratories
• 14.9 Amway Corporation
• 14.10 Herbalife Ltd.
• 14.11 BioGaia AB
• 14.12 Chr. Hansen Holding A/S
• 14.13 DuPont de Nemours Inc.
• 14.14 Arla Foods amba
• 14.15 Fonterra Co-operative Group Limited